California State Teachers Retirement System (CalSTRS)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Buy |
45,663
+4,531
| +11% | +$983K | 0.01% | 698 |
|
|
2026
Q1 | $6.95M | Buy |
41,132
+7,465
| +22% | +$1.29M | 0.01% | 850 |
|
|
2025
Q4 | $6.15M | Sell |
33,667
-648
| -2% | -$90.5K | 0.01% | 824 |
|
|
2025
Q3 | $4.17M | Buy |
34,315
+2
| +0% | +$225 | ﹤0.01% | 1024 |
|
|
2025
Q2 | $3.58M | Buy |
34,313
+5,108
| +17% | +$541K | ﹤0.01% | 1058 |
|
|
2025
Q1 | $3.41M | Sell |
29,205
-389
| -1% | -$44.3K | ﹤0.01% | 1055 |
|
|
2024
Q4 | $2.5M | Sell |
29,594
-14
| -0% | -$1.29K | ﹤0.01% | 1285 |
|
|
2024
Q3 | $2.66M | Sell |
29,608
-943
| -3% | -$82.3K | ﹤0.01% | 1246 |
|
|
2024
Q2 | $2.46M | Sell |
30,551
-700
| -2% | -$51.8K | ﹤0.01% | 1258 |
|
|
2024
Q1 | $2.49M | Sell |
31,251
-1,941
| -6% | -$163K | ﹤0.01% | 1278 |
|
|
2023
Q4 | $2.64M | Sell |
33,192
-3,396
| -9% | -$227K | ﹤0.01% | 1279 |
|
|
2023
Q3 | $2.56M | Sell |
36,588
-4,989
| -12% | -$373K | ﹤0.01% | 1248 |
|
|
2023
Q2 | $2.99M | Buy |
41,577
+1,042
| +3% | +$76.9K | ﹤0.01% | 1263 |
|
|
2023
Q1 | $2.5M | Buy |
40,535
+1,439
| +4% | +$94.5K | ﹤0.01% | 1353 |
|
|
2022
Q4 | $3.02M | Buy |
39,096
+2,238
| +6% | +$134K | ﹤0.01% | 1230 |
|
|
2022
Q3 | $1.65M | Buy |
36,858
+467
| +1% | +$23.3K | ﹤0.01% | 1558 |
|
|
2022
Q2 | $1.39M | Buy |
36,391
+3,499
| +11% | +$111K | ﹤0.01% | 1726 |
|
|
2022
Q1 | $1.36M | Sell |
32,892
-2,896
| -8% | -$89.8K | ﹤0.01% | 1863 |
|
|
2021
Q4 | $1.35M | Buy |
35,788
+809
| +2% | +$29.8K | ﹤0.01% | 1970 |
|
|
2021
Q3 | $1.15M | Sell |
34,979
-3,327
| -9% | -$130K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $2.58M | Sell |
38,306
-3,472
| -8% | -$208K | ﹤0.01% | 1633 |
|
|
2021
Q1 | $2.37M | Sell |
41,778
-139
| -0.3% | -$9.78K | ﹤0.01% | 1649 |
|
|
2020
Q4 | $3.42M | Sell |
41,917
-45
| -0.1% | -$3.37K | ﹤0.01% | 1342 |
|
|
2020
Q3 | $2.99M | Buy |
41,962
+189
| +0.5% | +$14.7K | ﹤0.01% | 1259 |
|
|
2020
Q2 | $3.44M | Buy |
41,773
+732
| +2% | +$56.3K | 0.01% | 1160 |
|
|
2020
Q1 | $2.41M | Buy |
41,041
+2,604
| +7% | +$212K | 0.01% | 1188 |
|
|
2019
Q4 | $3.97M | Sell |
38,437
-777
| -2% | -$31.4K | 0.01% | 1154 |
|
|
2019
Q3 | $794K | Buy |
39,214
+1,722
| +5% | +$44.2K | ﹤0.01% | 2075 |
|
|
2019
Q2 | $965K | Buy |
+37,492
| New | +$751K | ﹤0.01% | 1988 |
|
|
2017
Q2 | – | Sell |
-26,212
| Closed | -$102K | – | 3015 |
|
|
2017
Q1 | $102K | Buy |
26,212
+3,300
| +14% | +$15.8K | ﹤0.01% | 2926 |
|
|
2016
Q4 | $155K | Sell |
22,912
-300
| -1% | -$2.11K | ﹤0.01% | 2901 |
|
|
2016
Q3 | $183K | Sell |
23,212
-100
| -0.4% | -$757 | ﹤0.01% | 2883 |
|
|
2016
Q2 | $176K | Buy |
+23,312
| New | +$215K | ﹤0.01% | 2929 |
|
Other funds holding AXSM
DTC
California State Teachers Retirement System (CalSTRS)'s AXSM Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) increased its Axsome Therapeutics (AXSM) stake by 11% in Q2 2026, buying an estimated $983K and bringing the position to 45,663 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #698.
California State Teachers Retirement System (CalSTRS) first reported a position in AXSM in Q2 2016 and has held it in 33 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 45,663 shares of Axsome Therapeutics worth $11.2M as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) bought 4,531 Axsome Therapeutics shares in Q2 2026, an estimated $983K.
- Axsome Therapeutics made up 0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #698 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Axsome Therapeutics in Q2 2016 and has held it in 33 quarters since.
- 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.